Search Results 651-660 of 16924 for Amphotericin B
Giving inotuzumab ozogamicin with chemotherapy may work better in treating young adults with B acute lymphoblastic leukemia. A Study to Assess Adverse Events of ...
... B-. Cancer. Mayo Clinic prepares to biomanufacture a new CAR-T cell therapy for recurring B-cell blood cancers. Susan Buckles. October 10, 2023. Preparing to ...
... B, Swanson KR. Deep neural network to locate and segment brain tumors outperformed the expert technicians who created the training data. J Med Imaging ...
Pimienta AL, Billings TA, Fish RG. · Garrison GM, Traverse CR, Fish RG. · Lincoff AM, Tardif JC, Schwartz GG, Nicholls SJ, Ryden L, Neal B, Malmberg K, Wedel H, ...
Cell Therapy Targeting CD19 and B Cell Maturation Antigen in Participants With Relapsed or Refractory AL. Amyloidosis. The Biological Hazard Application ...
The subtypes we are studying are Diffuse Large B-Cell Lymphoma (DLBCL), Peripheral T-Cell Lymphoma (PTCL), Cutaneous T-Cell Lymphoma (CTCL), Primary Mediastinal ...
The purpose of this study is to provide access to CTL019 through Managed Access Program (MAP) for acute lymphoblastic leukemia (ALL) or diffuse large b-cell ...
... B, Knudson R, Greipp P, Brandt C, Koepplin J, Costello B, Heath E, Vasmatzis G, Florio A, Boorjian SA, Shah PH. Defining NECTIN4 Amplification and Protein ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.